XX

Xuechao Xing

EP Enanta Pharmaceuticals: 12 patents #3 of 28Top 15%
📍 Wilmington, MA: #1 of 38 inventorsTop 3%
🗺 Massachusetts: #121 of 14,267 inventorsTop 1%
Overall (2019): #5,552 of 560,194Top 1%
12
Patents 2019

Issued Patents 2019

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
10519191 Bile acid analogs as FXR/TGR5 agonists and methods of use thereof Yat Sun Or, Ruichao Shen, Peng Dai, Jiang Long, Guoqiang Wang 2019-12-31
10472386 Bile acid derivatives as FXR agonists and methods of use thereof Guoqiang Wang, Yat Sun Or, Ruichao Shen, Jiang Long, Peng Dai +2 more 2019-11-12
10457703 Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof Guoqiang Wang, Yat Sun Or, Ruichao Shen, Jiang Long, Peng Dai +2 more 2019-10-29
10450301 Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof Brett Granger, Guoqiang Wang, Ruichao Shen, Jing He, Yong He +4 more 2019-10-22
10450306 Isoxazole analogs as FXR agonists and methods of use thereof Jun Ma, Guoqiang Wang, Bin Wang, Ruichao Shen, Jing He +1 more 2019-10-22
10364267 Deuterated bile acid derivatives as FXR/TGR5 agonists and methods of use thereof Guoqiang Wang, Yat Sun Or, Jiang Long, Guoyou Xu, Peng Dai +2 more 2019-07-30
10323061 Heteroaryl containing bile acid analogs as FXR/TGR5 agonists and methods of use thereof Yat Sun Or, Jing He, Guoqiang Wang 2019-06-18
10323060 Benzoic acid derivatives of bile acid as FXR/TGR5 agonists and methods of use thereof Yat Sun Or, Guoqiang Wang, Ruichao Shen, Jing He 2019-06-18
10266560 Bile acid analogs as FXR/TGR5 agonists and methods of use thereof Yat Sun Or, Guoqiang Wang, Ruichao Shen 2019-04-23
10253018 Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof Guoqiang Wang, Brett Granger, Ruichao Shen, Yong He, Jun Ma +4 more 2019-04-09
10246439 Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof Brett Granger, Guoqiang Wang, Ruichao Shen, Jun Ma, Jing He +4 more 2019-04-02
10208081 Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof Guoqiang Wang, Yat Sun Or, Ruichao Shen, Jiang Long, Peng Dai +1 more 2019-02-19